Stool methylated DNA markers decrease following colorectal cancer resection - Implications for surveillance

Digestive Diseases and Sciences

Volumn 59, Issue 8, 2014, Pages 1764-1767

  Kisiel, John B ^a   Yab, Tracy C ^a   Taylor, William R ^a   Mahoney, Douglas W ^a   Ahlquist, David A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Colorectal neoplasms; DNA methylation; Feces analysis; Secondary prevention

Indexed keywords

BISULFITE; NDRG4 PROTEIN; OSTEOGENIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DNA DETERMINATION; DNA MARKER; DNA METHYLATION; FECES; FECES ANALYSIS; FEMALE; FOLLOW UP; GENE AMPLIFICATION; HUMAN; MALE; MARKER GENE; PERITONEUM METASTASIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN 3; CASE-CONTROL STUDIES; COLECTOMY; COLORECTAL NEOPLASMS; DNA METHYLATION; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; NERVE TISSUE PROTEINS; POPULATION SURVEILLANCE; TUMOR MARKERS, BIOLOGICAL;

EID: 84906101070     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3265-5     Document Type: Article

References (12)

1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American college of radiology. Gastroenterology. 2008;134:1570-1595. (Pubitemid 351615355)
2. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American college of gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol. 2009;104:739-750.
3. Shen L, Kondo Y, Rosner GL, et al. Mgmt promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst. 2005;97:1330-1338. (Pubitemid 41487800)
4. Edge SBB, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC cancer staging manual. 7th ed. New York: Springer; 2010:646.
5. Rex DK, Kahi CJ, Levin B, et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American cancer society and the US multi-society task force on colorectal cancer. Gastroenterology . 2006;130:1865-1871. (Pubitemid 43668858)
6. Lidgard GP, Domanico M, Bruinsma JJ, et al. An optimized multi-marker stool test for colorectal cancer screening: Initial clinical appraisal. Gastroenterology . 2012;142:S-770.
7. Lidgard GP, Domanico MJ, Bruinsma JJ, et al. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol . 2013;11:1313-1318.
8. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. New Engl J Med. 2014;370:1287-1297.
9. Syngal S, Stoffel E, Chung D, et al. Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer. 2006;106:277-283. (Pubitemid 43100434)
10. Zou H, Allawi H, Cao X, et al. Quantification of methylated markers with a multiplex methylation-specific technology. Clin Chem. 2012;58:375-383.
11. Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology. 2012;142:248-256.
12. Ahlquist DA, Taylor WR, Yab TC, et al. Aberrantly methylated gene marker levels in stool: effect of demographic exposure, body mass, and other patient characteristics. J Mol Biomark Diagn. 2012;3:133.